首页 › 股票 › KLRA

KLRA — KAILERA THERAPEUTICS INC

申报持仓市值$2.52B
持有基金数(最新)151
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)106
机构持仓市值$2.69B · 125.49M 股
新建/增持/减仓/清仓105 / 1 / 0 / 0 · 更新于 2026-11-14
前五大/前十大集中度59.1% / 73.8%
机构整体持仓变动 增持 +50.0% (+10.00K 股)
机构持仓市值变动 上升 +20.0%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 106 家机构在其最新 13F 申报中持有 KLRA(KAILERA THERAPEUTICS INC),合计申报市值 $2.69B,对应 125.49M 股。按股数计算较上季度增持 50.0%(+10.00K 股),申报市值环比上升 20.0%。持仓集中度较高:前五大持有人占申报市值的 59.1%,前十大的集中度为 73.8%。

与上一季度相比,105 家新建仓位、1 家加仓。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

KAILERA THERAPEUTICS INC(KLRA)的主要机构持有人包括 BAIN CAPITAL INVESTORS LLC、Bain Capital Life Sciences Investors, LLC、RTW INVESTMENTS, LP,按 13F 申报市值在本页 151 家持有人中排名居前。

KLRA 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 80 32.48M $371.48M +7.1%
Q2 2026 106 125.49M $2.69B +50.0%
Q1 2026 1 20.00K $26.00K +0.0%
Q4 2025 1 20.00K $23.20K —
Q4 2023 7 142.02K $44.04M +139.9%
Q3 2023 6 45.60K $7.42M —
Q2 2023 1 130.00K $28.19M +983.3%
Q1 2023 1 12.00K $2.18M +114.3%

表内 8 个季度中,机构持股合计增加 270558%(Q1 2023 → Q3 2026);单季变动最大的是 Q2 2023(+983.3%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Atlas Venture Life Science Advisors, LLC 历史持仓 5.17M $59.06M 9.36% 持有
Fidelity Management & Research (FMR) 4.66M $53.22M 0.00% 增持
BlackRock Inc 4.57M $52.22M 0.00% 增持
Royalty Pharma Sub-Manager, LLC 历史持仓 2.46M $28.04M 14.29% 持有
STATE STREET CORP 2.24M $25.60M 0.00% 新进
Siren, L.L.C. 历史持仓 2.21M $25.29M 0.60% 持有
VANGUARD CAPITAL MANAGEMENT LLC 1.68M $19.21M 0.00% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.62M $18.50M 0.00% 减持
Geode Capital Management 1.21M $13.79M 0.00% 增持
Marshall Wace 878.20K $10.03M 0.02% 新进
UBS Group AG 469.58K $5.36M 0.00% 减持
Franklin Resources 401.44K $5.14M 0.00% 持有
Aberdeen Group plc 432.66K $4.94M 0.01% 增持
Walleye Capital LLC 416.85K $4.76M 0.03% 新进
FEDERATED HERMES, INC. 403.69K $4.61M 0.01% 减持
Jump Financial, LLC 381.00K $4.35M 0.04% 新进
BNP PARIBAS FINANCIAL MARKETS 310.27K $3.54M 0.01% 增持
VANGUARD FIDUCIARY TRUST CO 290.14K $3.31M 0.00% 持有
EXCHANGE TRADED CONCEPTS, LLC 260.80K $2.98M 0.01% 增持
Renaissance Technologies 198.55K $2.27M 0.00% 新进
ALPS ADVISORS INC 171.74K $1.96M 0.01% 增持
Morgan Stanley 155.40K $1.77M 0.00% 增持
HRT FINANCIAL LP 151.00K $1.72M 0.01% 新进
Nuveen, LLC 147.19K $1.68M 0.00% 增持
BNY Mellon 140.93K $1.61M 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
BAIN CAPITAL INVESTORS LLC 历史持仓 26.26M $578.41M 12.01% 新进
Bain Capital Life Sciences Investors, LLC 历史持仓 22.58M $497.51M 29.58% 新进
RTW INVESTMENTS, LP 历史持仓 10.78M $237.41M 2.03% 新进
CPP Investments 7.30M $160.92M 0.09% 新进
Atlas Venture Life Science Advisors, LLC 历史持仓 5.17M $113.92M 12.93% 新进
Fidelity Management & Research (FMR) 3.97M $87.48M 0.00% 新进
BlackRock Inc 3.93M $86.55M 0.00% 新进
PRICE T ROWE ASSOCIATES INC /MD/ 3.53M $77.86M 0.01% 新进
Citadel Advisors 3.24M $71.39M 0.09% 新进
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.21M $70.68M 0.10% 新进
Wellington Management Group 2.92M $64.31M 0.01% 新进
WELLINGTON MANAGEMENT GROUP LLP 2.92M $64.31M 0.01% 新进
Royalty Pharma Sub-Manager, LLC 历史持仓 2.46M $54.09M 22.36% 新进
Siren, L.L.C. 历史持仓 2.21M $48.78M 0.99% 新进
VANGUARD CAPITAL MANAGEMENT LLC 1.69M $37.32M 0.00% 新进
VANGUARD PORTFOLIO MANAGEMENT LLC 1.65M $36.40M 0.00% 新进
GEODE CAPITAL MANAGEMENT, LLC 1.13M $24.97M 0.00% 新进
Geode Capital Management 1.13M $24.97M 0.00% 新进
Farallon Capital Management 历史持仓 1.10M $24.23M 0.11% 新进
FARALLON CAPITAL MANAGEMENT, L.L.C. 历史持仓 1.10M $24.23M 0.11% 新进
Frazier Life Sciences Management, L.P. 历史持仓 1.10M $24.23M 0.53% 新进
Trails Edge Capital Partners, LP 历史持仓 984.79K $21.69M 3.44% 新进
UBS Group AG 972.68K $21.43M 0.01% 新进
Jupiter Topco LLC 970.86K $21.34M 0.01% 新进
AMERIPRISE FINANCIAL INC 821.33K $18.09M 0.00% 新进

Q1 2026 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 20.00K $26.00K 0.00% 持有

Q4 2025 — 1 家基金

基金股数金额组合权重变化
Ancora Advisors LLC 20.00K $23.20K 0.00% 新进

Q4 2023 — 7 家基金

基金股数金额组合权重变化
JANE STREET GROUP, LLC 50.10K $15.86M 0.02% 增持
JPMorgan Chase & Co 50.00K $15.83M 0.00% 新进
SIMPLEX TRADING, LLC 24.00K $7.60M 0.03% 增持
GROUP ONE TRADING LLC 12.00K $3.80M 0.07% 增持
Legato Capital Management LLC 1.12K $353.54K 0.05% 减持
Maven Securities LTD 1.00K $316.51K 0.03% 新进
Worth Venture Partners, LLC 3.80K $292.79K 0.20% 新进

Q3 2023 — 6 家基金

基金股数金额组合权重变化
JANE STREET GROUP, LLC 22.40K $3.79M 0.01% 新进
Twin Tree Management, LP 7.50K $1.27M 0.01% 新进
SIMPLEX TRADING, LLC 6.70K $1.13M 0.01% 新进
GROUP ONE TRADING LLC 4.90K $828.54K 0.02% 新进
Legato Capital Management LLC 2.35K $397.19K 0.06% 新进
INVESTOR AB 1.75K $4.21K 0.00% 新进

查看全部 151 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Atlas Venture Life Science Advisors, LLC 5.17M 5.17M — — — — — — — —
Fidelity Management & Research (FMR) 4.66M 3.97M — — — — — — — —
BlackRock Inc 4.57M 3.93M — — — — — — — —
Royalty Pharma Sub-Manager, LLC 2.46M 2.46M — — — — — — — —
STATE STREET CORP 2.24M — — — — — — — — —
Siren, L.L.C. 2.21M 2.21M — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 1.68M 1.69M — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 1.62M 1.65M — — — — — — — —
Geode Capital Management 1.21M 1.13M — — — — — — — —
Marshall Wace 878.20K — — — — — — — — —
UBS Group AG 469.58K 972.68K — — — — — — — —
Franklin Resources 401.44K 400.02K — — — — — — — —
Aberdeen Group plc 432.66K 140.00K — — — — — — — —
Walleye Capital LLC 416.85K — — — — — — — — —
FEDERATED HERMES, INC. 403.69K 434.07K — — — — — — — —
Jump Financial, LLC 381.00K — — — — — — — — —
BNP PARIBAS FINANCIAL MARKETS 310.27K 7.00K — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 290.14K 290.13K — — — — — — — —
EXCHANGE TRADED CONCEPTS, LLC 260.80K 152.50K — — — — — — — —
Renaissance Technologies 198.55K — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold KLRA?

As of 2026-Q2, 106 institutional funds reported holding KLRA (KAILERA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.69B.

How many shares of KLRA do institutions own?

13F filers reported 125.49M shares of KLRA, worth $2.69B in aggregate at the end of 2026-Q2.

Is institutional ownership of KLRA rising or falling?

Share counts moved +50.0% versus the prior quarter — accumulation.

Who are the top institutional holders of KLRA?

The largest 13F holders are BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, CPP Investments, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.

Who are the major shareholders of KAILERA THERAPEUTICS INC?

The major shareholders of KAILERA THERAPEUTICS INC (KLRA) by reported 13F value are BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, CPP Investments, PRICE T ROWE ASSOCIATES INC /MD/, among 151 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 KLRA」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/KLRA/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →